<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03156218</url>
  </required_header>
  <id_info>
    <org_study_id>NL61945.029.17</org_study_id>
    <nct_id>NCT03156218</nct_id>
  </id_info>
  <brief_title>The Effect of FiO2 on PaO2/FiO2 Ratio</brief_title>
  <official_title>The Effect of Inspiratory Oxygen Fraction on the Ratio of Partial Arterial Oxygen Pressure and Inspiratory Oxygen Fraction (PaO2/FiO2 Ratio) in Mechanically Ventilated Patients With and Without Mild to Moderate ARDS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PaO2/FiO2 ratio is frequently used to determine the severity of lung injury in&#xD;
      mechanically ventilated patients. However, several mathematical models have shown that&#xD;
      PaO2/FiO2 ratio depends on FiO2. The relationship is complex and depends on numerous&#xD;
      physiological variables, including shunt fraction, and arterio-venous oxygen difference. The&#xD;
      nonlinear relation between PaO2/FiO2 and FiO2 underlines the limitations describing the&#xD;
      intensity of hypoxemia using PaO2/FiO2 and is thus of major importance for the clinician.&#xD;
      Surprisingly, this relationship has only been assessed mathematically. Obviously, the&#xD;
      accuracy of the mathematical relationship depends on the input variables used.&#xD;
&#xD;
      The current study is designed to assess the PaO2/FiO2 vs FiO2 relation in mechanically&#xD;
      ventilated patients without ARDS (n =10) and with mild or moderate ARDS (n =10). In order to&#xD;
      explain the dependency of the PaO2/FiO2 on FiO2, shunt fraction and alveolar - arterial&#xD;
      oxygen difference ((A-a)DO2) will be determined in these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale:&#xD;
&#xD;
      The PaO2/FiO2 ratio is frequently used to determine the severity of lung injury in&#xD;
      mechanically ventilated patients. However, several mathematical models have shown that&#xD;
      PaO2/FiO2 ratio depends on FiO2. The relationship is complex and depends on numerous&#xD;
      physiological variables, including shunt fraction, and arterio-venous oxygen difference. The&#xD;
      nonlinear relation between PaO2/FiO2 and FiO2 underlines the limitations describing the&#xD;
      intensity of hypoxemia using PaO2/FiO2 and is thus of major importance for the clinician.&#xD;
      Surprisingly, this relationship has only been assessed mathematically. Obviously, the&#xD;
      accuracy of the mathematical relationship depends on the input variables used.&#xD;
&#xD;
      The current study is designed to assess the PaO2/FiO2 vs FiO2 relation in mechanically&#xD;
      ventilated patients without ARDS (n =10) and with mild or moderate ARDS (n =10). In order to&#xD;
      explain the dependency of the PaO2/FiO2 on FiO2, shunt fraction and alveolar - arterial&#xD;
      oxygen difference ((A-a)DO2) will be determined in these patients.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      To study the relation between PaO2/FiO2-ratio and FiO2&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      An unblinded, prospective, interventional study&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      Mechanically ventilated patients &gt; 18 years, admitted to the Intensive Care Unit of&#xD;
      VU-Medical Center post cardiac surgery without ARDS (n = 10) and with mild to moderate ARDS&#xD;
      (n = 10).&#xD;
&#xD;
      Intervention:&#xD;
&#xD;
      Two interventions will be performed:&#xD;
&#xD;
        1. Modulation of FiO2: FiO2 will be reduced to 21% or until peripheral oxygen saturation of&#xD;
           92%, whatever occurs first. Subsequently FiO2 will be increased up to 100%.&#xD;
&#xD;
        2. Withdrawal of blood: Blood will be withdrawn from the indwelling arterial line and&#xD;
           pulmonary artery catheter. No catheters will be inserted for the study. The maximum&#xD;
           number of time points is 7. At each time point 1.5 ml of blood will be withdrawn from&#xD;
           both the arterial and pulmonary artery catheter for blood gas analysis. At the start and&#xD;
           the end of the study period 2 additional blood samples of 5 ml each will be drawn.&#xD;
           Accordingly, the maximum amount of blood obtained will be less than 50 ml.&#xD;
&#xD;
      Main study parameters/endpoints:&#xD;
&#xD;
      At each level of FiO2 the following parameters will be assessed:&#xD;
&#xD;
        -  Arterial blood gas analysis, including SaO2&#xD;
&#xD;
        -  Central Venous oxygen saturation and content&#xD;
&#xD;
        -  Hemoglobin&#xD;
&#xD;
        -  Body temperature&#xD;
&#xD;
        -  End tidal CO2&#xD;
&#xD;
        -  VO2 and VCO2&#xD;
&#xD;
        -  Ventilatory parameters (tidal volume, respiratory rate, Ppeak Paw)&#xD;
&#xD;
        -  Hemodynamics (Bloodpressure and Heart Rate)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>In both groups FiO2 will be modulated: FiO2 will be reduced to 21% or until peripheral oxygen saturation of 92%, whatever occurs first. Subsequently FiO2 will be increased up to 100%.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of FiO2 on the PaO2/FiO2-ratio</measure>
    <time_frame>2 hours</time_frame>
    <description>To study the effect of FiO2 on the PaO2/FiO2-ratio in mechanically ventilated patients post cardiac surgery without ARDS and with mild to moderate ARDS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Shunt fraction, arteriovenous oxygen difference and alveolar - arterial oxygen difference</measure>
    <time_frame>2 hours</time_frame>
    <description>Shunt fraction, arteriovenous oxygen difference and alveolar - arterial oxygen difference will be determined to explain the relationship between FiO2 and the PaO2/FiO2-ratio</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>PaO2/FiO2 Ratio</condition>
  <arm_group>
    <arm_group_label>Without ARDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients admitted to the ICU after cardiac surgery with a PaO2/FiO2 ratio &gt; 300.&#xD;
Modulation of FiO2: FiO2 will be reduced to 21% or until peripheral oxygen saturation of 92%, whatever occurs first. Subsequently FiO2 will be increased up to 100%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>With mild to moderate ARDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients admitted to the ICU after cardiac surgery with a PaO2/FiO2 ratio &gt; 100 and &lt; 300.&#xD;
Modulation of FiO2: FiO2 will be reduced to 21% or until peripheral oxygen saturation of 92%, whatever occurs first. Subsequently FiO2 will be increased up to 100%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Modulation of FiO2</intervention_name>
    <description>Modulation of FiO2: FiO2 will be reduced to 21% or until peripheral oxygen saturation of 92%, whatever occurs first. Subsequently FiO2 will be increased up to 100%.</description>
    <arm_group_label>With mild to moderate ARDS</arm_group_label>
    <arm_group_label>Without ARDS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All mechanically ventilated patients, admitted to the Intensive Care Unit of VU-Medical&#xD;
        Center post cardiac surgery without ARDS and with mild to moderate ARDS. In order to be&#xD;
        eligible to participate in this study, a subject must meet all of the following criteria:&#xD;
&#xD;
          -  Mechanically ventilated patients&#xD;
&#xD;
          -  Stable hemodynamics&#xD;
&#xD;
          -  Stable haemoglobin level&#xD;
&#xD;
          -  Stable body temperature&#xD;
&#xD;
          -  Stable level of sedation&#xD;
&#xD;
          -  Pulmonary-Artery and Artery catheter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Incomplete revascularization after CABG&#xD;
&#xD;
          -  Cardiac ischemia&#xD;
&#xD;
          -  Neurotrauma&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angelique Spoelstra - de Man, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angelique Spoelstra - de Man, MD, PhD</last_name>
    <phone>+31204443924</phone>
    <email>am.spoelstra@vumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leo Heunks, MD, PhD</last_name>
    <phone>+31204443924</phone>
    <email>l.heunks@vumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelique Spoelstra - de Man, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>Angelique Spoelstra-de Man</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

